# GHK-Cu (Copper Tripeptide) - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: Glycyl-L-histidyl-L-lysine copper (GHK-Cu) is a naturally occurring human plasma tripeptide whose endogenous levels decline by >60% from age 20 to 60. Broad Institute Connectivity Map profiling reveals that GHK-Cu modulates expression of over 4,000 human genes—resetting gene expression in aging tissues towards a youthful phenotype. It upregulates DNA repair genes, stimulates procollagen I and III, elastin, and glycosaminoglycan synthesis, accelerates wound healing, attenuates chronic inflammation (NF-κB and TGF-β1 suppression), and restores proteasome activity.

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **89/100**
- **Evidence Quality Tier**: **silver**
- **Human Clinical Evidence Strength**: 87/100
- **Primary Longevity Classification**: peptides
- **Safety Margin Score**: 92/100 (Higher is safer)
- **Time Burden**: ~3 minutes/day
- **Estimated Monthly Cost**: inexpensive
- **Adherence Friction**: 2/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
Unrivaled broad genomic rejuvenating tripeptide modulating over 4,000 genes with profound collagen, antioxidant, and tissue-protective safety profile.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Heart Health & Endothelial Function**: **68/100** [Rank #72 of 133 in Heart] - Effect: Moderate (Microvascular angiogenesis and vascular endothelial repair)
    - Mechanism: Induces VEGF and bFGF transcription, stimulating microvascular revascularization in ischemic tissues.
- **Brain Longevity & Neuroprotection**: **80/100** [Rank #42 of 141 in Brain] - Effect: Strong (Suppresses neuroinflammation, chelates neurotoxic iron/copper ions, and promotes nerve outgrowth)
    - Mechanism: Crosses into neural tissues to scavenge toxic hydroxyl radicals, chelate redox-active metal ions, and stimulate nerve growth factor (NGF).
- **Metabolic Flexibility & Glycemic Control**: **62/100** [Rank #73 of 129 in Metabolic] - Effect: Moderate (Antioxidant and anti-glycation protection of cell membranes)
    - Mechanism: Inhibits lipid peroxidation and blocks reactive aldehyde cross-linking to prevent advanced glycation end-product accumulation.
- **Cancer Defense & DNA Repair**: **75/100** [Rank #16 of 120 in Cancer Defense] - Effect: Strong (Broad Institute Connectivity Map #1 candidate for reversing aggressive metastatic gene signatures)
    - Mechanism: Downregulates oncogenic node networks and restores normal contact inhibition and apoptosis pathways in aberrant cells.
- **Endocrine & Anabolic Balance**: **50/100** [Rank #45 of 120 in Endocrine] - Effect: Neutral (No hormonal axis modulation)
    - Mechanism: Does not directly interact with steroidogenic nuclear hormone receptors.
- **Chronic Inflammation Reduction**: **90/100** [Rank #8 of 126 in Inflammation] - Effect: Strong (Direct suppression of TGF-beta1, TNF-alpha, IL-6, and oxidative burst)
    - Mechanism: Suppresses pro-fibrotic TGF-beta1 and downregulates NF-kB inflammatory signaling across human dermal fibroblasts and macrophages.
- **Bone Density & Connective Matrix**: **72/100** [Rank #53 of 142 in Bone Matrix] - Effect: Moderate (Stimulates mesenchymal stem cell osteogenic differentiation and collagenous matrix)
    - Mechanism: Enhances copper delivery to lysyl oxidase (LOX), catalyzing collagen and elastin cross-linking within bone and connective tissues.
- **Cellular Longevity & Autophagy**: **94/100** [Rank #13 of 131 in Cellular] - Effect: Exceptional (Resets 4,000+ genes to youthful baseline, upregulates DNA repair and procollagen I/III)
    - Mechanism: Epigenetically reprograms cellular gene expression, stimulates master antioxidant enzymes (SOD, catalase), and upregulates DNA repair pathways.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: Refer to individualized clinical assessment
- **Recommended Timing**: Consistent daily schedule
- **Administration Type**: Behavioral / Compound
- **Recommended Biomarkers to Monitor**: skin_clarity, immune_resilience, bone_density, heart_health, testosterone, cancer_defense

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: Wilson’s disease (genetic copper accumulation disorder), Active hypercupremia or severely elevated ceruloplasmin, Known contact allergy to copper compounds
- **Safety Profile**: High Margin - Transient localized dermal stinging if high-concentration topical peptide is applied to broken skin; Mild local injection-site sting (subcutaneous administration)

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data** [PMID: 29986520]
   - Link: https://pubmed.ncbi.nlm.nih.gov/29986520/
2. **The human copper-binding peptide GHK-Cu reverses gene expression signature of aggressive lung cancer metastasis** [PMID: 22464731]
   - Link: https://pubmed.ncbi.nlm.nih.gov/22464731/
3. **GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration and Aging Gene Expression** [PMID: 26090430]
   - Link: https://pubmed.ncbi.nlm.nih.gov/26090430/
4. **Effect of copper peptide GHK-Cu on hair follicle enlargement and anagen growth** [PMID: 8326154]
   - Link: https://pubmed.ncbi.nlm.nih.gov/8326154/
5. **Copper peptide GHK-Cu in cosmetics: A randomized comparative clinical trial** [PMID: 16422478]
   - Link: https://pubmed.ncbi.nlm.nih.gov/16422478/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [GHK-Cu (Copper Tripeptide) on LongevityReviews](https://longevityreviews.org/modalities/ghk-cu)
- **Last Evidence Calibration**: 2026-09-09
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.